Repligen Corp at Stifel Healthcare Conference (Virtual) Transcript

Nov 17, 2021 / 01:00PM GMT
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Welcome back, everyone. This is Day 3 of the Stifel Healthcare Conference, and we are on the life sciences and diagnostics track. And with us, to kick things off this morning, is Repligen. We have CEO, Tony Hunt; and CFO, Jon Snodgres, with us. Guys, thanks a bunch for joining us today and spending some time talking.

Anthony J. Hunt - Repligen Corporation - CEO, President & Director

Great. Good to be here, Dan.

Questions and Answers:

Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Yes. So Tony, we've taken a bit of a step backwards since June when we got together, and it felt like the virtual stuff was winding down, but we're -- it's okay. We're getting there. Hopefully, we get there soon anyway. And during that time, the business continues to perform well. 2021 is going to be another good year for you guys.

So can
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot